Skip to content

Clinical Application of Nutrition Support Package Before Hepatectomy

Clinical Application of Preoperative Nutritional Support Package for Liver Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04218253
Enrollment
200
Registered
2020-01-06
Start date
2019-10-01
Completion date
2022-06-30
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatectomy, Liver Neoplasms, Nutrition Therapy

Keywords

Nutrition Therapy, Hepatectomy

Brief summary

Objective:To confirm the effect of preoperative oral nutrition therapy on patients with malnourished before liver cancer resection. Study design:Prospective, randomized, controlled clinical study. Primary end point: incidence of all complications 30 days after surgery.

Interventions

DIETARY_SUPPLEMENT300 calories or 500 calories nutrient rich in branched chain amino acids and dietary fiber

300 kcal rich in branched chain amino acids and water soluble dietary fiber (12g) for Mild malnutrition, or 500 kcal rich in branched chain amino acids and water soluble dietary fiber (12g) for moderate to severe malnutrition. The degree of malnutrition is determined by Patient-Generated Subjective Global Assessment (PG-SGA).

BEHAVIORALDietary mission

Dietary education was conducted according to preoperative nutritional requirements

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Clinical diagnosis of primary liver cancer (including hepatocellular carcinoma, bile duct carcinoma, and mixed cell carcinoma) * 2\. No contraindications for surgery * 3\. Eastern Cooperative Oncology Group (ECOG) score of preoperative physical state \<2 points * 4\. Preoperative liver function score Child-Pugh ≤ 6 points: total bilirubin ≤ 3.0 mg / dl, albumin ≥ 28 g / L, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) ≤ 5 times the upper limit of normal * 5\. Voluntarily enter the study and sign the informed consent form, and communicate well with the researcher

Exclusion criteria

* 1\. Patients who took fish oil supplements within 3 weeks before the study began * 2\. Patients with severe nutritional risk: serious nutritional risk should be considered when combining any of the following conditions: weight loss \> 10% within 6 months; digital pain score (NRS) score \> 5 points; BMI \<18.5 kg/m2 (all patients with severe nutritional risk undergo individualized supportive care); * 3\. Patients with malignant tumors in other parts * 4\. Patients who are pregnant or lactating * 5\. Patients with mental and neurological disorders who cannot cooperate with medical staff * 6\. Patients with severe diabetes or poor glycemic control * 7\. Patients cannot tolerate nutritional preparations * 8\. Other circumstances that the researcher considers inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Incidence of complications at 30 days after surgeryup to 30 days after surgeryPostoperative complications were defined by Clavien-Dindo. Grade 1: Any deviation from the normal postoperative course without the need for pharmacologic treatment or surgical, endoscopic, and radiologic interventions. Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgetics, and diuretics, and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade 2: Requiring pharmacologic treatment with drugs other than such allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included. Grade 3: Requiring surgical, endoscopic, or radiologic intervention 3a: Intervention not under general anesthesia 3b: Intervention under general anesthesia Grade 4:Life-threatening complication (including CNS complications) requiring IC/ICU management. 4a: Single organ dysfunction (including dialysis) 4b: Multiple organ dysfunction Grade 5: Death as a result of complications

Secondary

MeasureTime frameDescription
Postoperative hospital stayup to 90 days after surgeryfrom the date of the operation to the date of discharge

Countries

China

Contacts

Primary ContactChunlei Li, Doctor
lcltjmu507@163.com18622370261
Backup ContactKun Wang, Doctor
lcltjmu507@163.com23340123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026